Grant: CIHR Fellowship
Direct Payment
$150,000.00
IPSC and in vivo approaches to understand Parkinson's disease dementia and potential therapies
EF 2011-12
Résumé
Parkinson's disease dementia (PDD) affects over 80% of patients who have had PD for 20 years. Risk factors have recently been identified for PDD, however how these cause the dementia is still unclear but seems to involve a combination of specific protein interactions inside nerve cells in association with abnormalities in the power house of that cell (mitochondria), combined with the loss a specific chemical messenger (acetylcholine) to it. Using a novel cell culture approach that involves making nerve cells from the skin cells of PD patients, we will look at how these nerve cells behave when derived from patients at low and high risk of PDD. We will do this by seeing what happens to these cells over time when they are stressed and challenged with different acetylcholine like agents. We will evaluate their survival and health as well as how well they respond to a novel therapeutic strategy targeting mitochondria. This work will also extend to a new transgenic mouse model of PD.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
254725
Name
Drouin-Ouellet Janelle
Country
United Kingdom
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
IPSC and in vivo approaches to understand Parkinson's disease dementia and potential therapies
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Alpha-Synuclein; Cholinergic Agents; Dementia; Inducible Pluripotent Stem Cells; Mitochondrial Dysfunctions; Non-Coding Rna; Parkinson'S Disease; Tau; Tau Haplotypes; Transgenic Mice
Abstract
Parkinson's disease dementia (PDD) affects over 80% of patients who have had PD for 20 years. Risk factors have recently been identified for PDD, however how these cause the dementia is still unclear but seems to involve a combination of specific protein interactions inside nerve cells in association with abnormalities in the power house of that cell (mitochondria), combined with the loss a specific chemical messenger (acetylcholine) to it. Using a novel cell culture approach that involves making nerve cells from the skin cells of PD patients, we will look at how these nerve cells behave when derived from patients at low and high risk of PDD. We will do this by seeing what happens to these cells over time when they are stressed and challenged with different acetylcholine like agents. We will evaluate their survival and health as well as how well they respond to a novel therapeutic strategy targeting mitochondria. This work will also extend to a new transgenic mouse model of PD.
Competitiondate
201202
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Drouin-Ouellet, Janelle
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~